Susquehanna International Group, LLP Scynexis Inc Put Options Transaction History

Susquehanna International Group, LLP

6 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q1 2024 May 07, 2024	BUY	$1.39 - $2.21 $2,780 - $4,420	2,000 Added 18.35%	12,900 $18,000
Q4 2023 Feb 14, 2024	SELL	$1.56 - $2.24 $11,076 - $15,904	-7,100 Reduced 39.44%	10,900 $24,000
Q3 2023 Nov 14, 2023	BUY	$1.93 - $3.64 $4,632 - $8,736	2,400 Added 15.38%	18,000 $41,000
Q2 2023 Aug 11, 2023	SELL	$2.38 - $3.67 $50,694 - $78,171	-21,300 Reduced 57.72%	15,600 $46,000
Q1 2023 May 16, 2023	BUY	$1.15 - $3.0 $42,435 - $110,700	36,900 New	36,900 $110,000
Q3 2022 Nov 14, 2022	BUY	$1.83 - $2.93 $18,666 - $29,886	10,200 New	10,200 $24,000

13.7M

21.9K

2.6K

Ticker SCYX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 32,651,800
Market Cap $33M
Description
SCYNEXIS, Inc., a biotechnology company, develops products for the treatment fungal infections in the United States. It offers BREXAFEMME (ibrexafungerp tablets) for the treatment of vulvovaginal candidiasis (VVC). The company is developing its lead product candidate, Ibrexafungerp, as a novel oral and intravenous drug for the treatment of vario...

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

Stay updated on Susquehanna International Group, LLP with notifications on news.